Medicamentos termoláveis: estabilidade após ruptura da cadeia de frio

Introdução. O Técnico de Farmácia entre as suas funções, tem a responsabilidade de garantir a conservação adequada dos medicamentos em todo o seu circuito. Deste modo, devem ser aplicados numa Instituição Hospitalar cuidados especiais desde a recepção da encomenda até à dispensa dos produtos termoláveis para os Serviços Clínicos. Pelo potencial impacto clínico e económico, é necessário ser apresentado um protocolo para a manutenção da cadeia de frio de forma a agir devidamente em caso de ruptura da cadeia de frio. Tal protocolo deve incluir, entre outras informações, uma lista de estabilidade dos diferentes medicamentos com o tempo e a temperatura a que podem ser expostos. Como tal, este estudo pretende estabelecer um procedimento padronizado, para agir em caso de ruptura da cadeia de frio, sobre a estabilidade de cada medicamento. Material e Métodos. O estudo carateriza-se como sendo uma revisão de literatura, de modo a compilar informação sobre um tema de acordo com um conjunto de critérios estabelecidos. A pesquisa incidiu sobre todos os produtos termoláveis existentes na instituição, com excepção dos medicamentos manipulados não estéreis que necessitam de refrigeração. Os critérios de análise destacados para a pesquisa foram o príncipio activo, nome comercial, laboratório produtor e a estabilidade à temperatura ambiente. Resultados. Para a realização do trabalho foi construída uma tabela resumo dos dados obtidos: produto versus critérios de análise, tendo sido analisados um total de 199 produtos. Discussão / Conclusões: As informações relativas à estabilidade dos produtos termoláveis permitem conhecer a segurança no seu uso em caso de ruptura da cadeia de frio, sendo que esses dados só devem ser aplicados em situações extremamente necessárias e não por rotina. Contrariamente ao esperado, este tipo de informação não se encontra frequentemente disponível no Resumo de Características do Medicamento assim como nos Folhetos Informativos, tornando difícil o acesso a esta informação. É ainda de ressalvar que o trabalho deverá ser actualizado continuamente, para a qualquer momento ser consultado, quer pela inexistência de informação para todos os produtos disponíveis nos Serviços Farmacêuticos, bem como pela possível e constante mudança de produtos ou laboratórios que existam na Instituição.

Introduction to the special issue on real world applications of intelligent tutoring systems

The idea behind creating this special issue on real world applications of intelligent tutoring systems was to bring together in a single publication some of the most important examples of success in the use of ITS technology. This will serve as a reference to all researchers working in the area. It will also be an important resource for the industry, showing the maturity of ITS technology and creating an atmosphere for funding new ITS projects. Simultaneously, it will be valuable to academic groups, motivating students for new ideas of ITS and promoting new academic research work in the area.

Nephrotoxicity of CCA-treated wood: a comparative study with As2O5 and CrO3 on mice

The purpose of this work was to assess the acute toxicity on male mice to a chromated copper arsenate (CCA) solution, a widespread wood preservative used in building industry until 2002. Animals were subcutaneously injected with CCA (7.2 mg/kg arsenic and 10.2 mg/kg chromium per body weight), CrO3 (10.2 mg/kg), As2O5 (7.2 mg/kg) and NaCl (0.9%) per se, during 48 h and 96 h, for histopathology, histochemistry, chromium and arsenic analysis. The results showed some histopathological changes within renal tubules lumen of CCA exposed animals (during 48 h, and 96 h), and CrO3 (for the period of 96 h). Furthermore, the renal levels of arsenic and chromium in treated animals were statistically more evident than controls. Although, the same contents of pentavalent arsenic and hexavalent chromium were injected into treated animals with CCA and with the prepared solutions of As2O5 and CrO3, a different distribution of the pattern of these compounds was observed in kidneys.

BabeLO : an extensible converter of programming exercises formats

In the last two decades, there was a proliferation of programming exercise formats that hinders interoperability in automatic assessment. In the lack of a widely accepted standard, a pragmatic solution is to convert content among the existing formats. BabeLO is a programming exercise converter providing services to a network of heterogeneous e-learning systems such as contest management systems, programming exercise authoring tools, evaluation engines and repositories of learning objects. Its main feature is the use of a pivotal format to achieve greater extensibility. This approach simplifies the extension to other formats, just requiring the conversion to and from the pivotal format. This paper starts with an analysis of programming exercise formats representative of the existing diversity. This analysis sets the context for the proposed approach to exercise conversion and to the description of the pivotal data format. The abstract service definition is the basis for the design of BabeLO, its components and web service interface. This paper includes a report on the use of BabeLO in two concrete scenarios: to relocate exercises to a different repository, and to use an evaluation engine in a network of heterogeneous systems.

An integrated reusable remote laboratory to complement electronics teaching

The great majority of the courses on science and technology areas where lab work is a fundamental part of the apprenticeship was not until recently available to be taught at distance. This reality is changing with the dissemination of remote laboratories. Supported by resources based on new information and communication technologies, it is now possible to remotely control a wide variety of real laboratories. However, most of them are designed specifically to this purpose, are inflexible and only on its functionality they resemble the real ones. In this paper, an alternative remote lab infrastructure devoted to the study of electronics is presented. Its main characteristics are, from a teacher's perspective, reusability and simplicity of use, and from a students' point of view, an exact replication of the real lab, enabling them to complement or finish at home the work started at class. The remote laboratory is integrated in the Learning Management System in use at the school, and therefore, may be combined with other web experiments and e-learning strategies, while safeguarding security access issues.

Papilomatose Respiratória Recorrente

A papilomatose respiratória recorrente da criança é uma doença rara, mas potencialmente ameaçadora da vida, e que atinge o trato respiratório com predilecção pela laringe e traqueia. É causada pelo papiloma-vírus humano (tipo 6 e 11). É uma das causas de rouquidão e obstrução da via aérea. É necessário um elevado grau de suspeição diagnóstica, tendo em conta as várias formas de apresentação. Apresenta-se o caso de uma criança de quatro anos de idade, com antecedentes de papilomatose laríngea, internada por obstrução respiratória alta grave e necessidade de traqueotomia de emergência. A tipagem viral realizada posteriormente revelou tratar-se do papilomavírus humano tipo 11 e 72. Nos catorze meses seguintes foi submetida a seis intervenções cirúrgicas, inicialmente por técnicas convencionais e laser de CO2, e de seguida utilizando o novo método de microdebridador e aplicação de cidofovir intralesional. Trata-se de um caso ilustrativo de doença extremamente agressiva, que pôs em risco a vida da criança e com óbvia repercussão na sua qualidade de vida. A papilomatose respiratória recorrente, embora rara, deve estar presente nos diagnósticos diferenciais de estridor na criança, de modo a prevenir o crescimento de papilomas e a consequente obstrução grave das vias aéreas.

Boa Londres é esta : em torno das revoltas populares de 1381 e 1383

Um dos fenómenos com que o especialista ou simples interessado na Baixa Idade Média europeia mais frequentemente se depara é, sem dúvida, a caracterização desse século XIV que a voz abalizada de Duby crismaria de “viragem” (Duby 1989: 173) como marcado pela instabilidade, precaridade e incerteza próprias de todo um mundo composto de mudança. Respigando ao acaso algumas obras produzidas pela historiografia inglesa, esperam-nos etiquetas e descrições como Hierarchy and Revolt (Holmes 1975), 2 “Order and Conflict” (Briggs 1985: 82), The Age of Adversity (Lerner 1968), An Age of Ambition (Du Boulay 1970), “the century of war, plague and disorder” (McDowall 1995: 43), etc. Elucidativo é também o subtítulo de um romance histórico de Barbara Tuchman: A Distant Mirror. The Calamitous Fourteenth Century (Tuchman 1980). Descontando o que nesta representação possa existir ou subsistir de subjectivo ou convencional, o século XIV foi, ainda assim, dentro e fora de Inglaterra, um período de profundas tensões, convulsões e mutações de ordem demográfica, económica, social, laboral, política e religiosa; fustigado pela Peste Negra (1348-49), por insurreições populares como a Jacquerie (1358), os Ciompi (1378), os Maillotins (1382) ou a Revolta dos Camponeses (1381), por cisões religiosas e teológicas como o Grande Cisma do Ocidente (1378-1417) e o aparecimento dos lollards, a partir da década de 1370.

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

PURPOSE: Temozolomide is a novel oral alkylating agent with demonstrated efficacy as second-line therapy for patients with recurrent anaplastic astrocytoma and glioblastoma multiforme (GBM). This phase II study was performed to determine the safety, tolerability, and efficacy of concomitant radiation plus temozolomide therapy followed by adjuvant temozolomide therapy in patients with newly diagnosed GBM. PATIENTS AND METHODS: Sixty-four patients were enrolled onto this open-label, phase II trial. Temozolomide (75 mg/m(2)/d x 7 d/wk for 6 weeks) was administered orally concomitant with fractionated radiotherapy (60 Gy total dose: 2 Gy x 5 d/wk for 6 weeks) followed by temozolomide monotherapy (200 mg/m(2)/d x 5 days, every 28 days for six cycles). The primary end points were safety and tolerability, and the secondary end point was overall survival. RESULTS: Concomitant radiation plus temozolomide therapy was safe and well tolerated. Nonhematologic toxicities were rare and mild to moderate in severity. During the concomitant treatment phase, grade 3 or 4 neutropenia, thrombocytopenia, or both were observed in 6% of patients, including two severe infections with Pneumocystis carinii. During adjuvant temozolomide, 2% and 6% of cycles were associated with grade 3 and 4 neutropenia or thrombocytopenia, respectively. Median survival was 16 months, and the 1- and 2-year survival rates were 58% and 31%, respectively. Patients younger than 50 years old and patients who underwent debulking surgery had the best survival outcome. CONCLUSION: Continuous daily temozolomide and concomitant radiation is safe. This regimen of concomitant chemoradiotherapy followed by adjuvant chemotherapy may prolong the survival of patients with glioblastoma. Further investigation is warranted, and a randomized trial is ongoing.

Factors associated with favorable drinking outcome 12 months after hospitalization in a prospective cohort study of inpatients with unhealthy alcohol use.

BACKGROUND: Prevalence of unhealthy alcohol use among medical inpatients is high. OBJECTIVE: To characterize the course and outcomes of unhealthy alcohol use, and factors associated with these outcomes. DESIGN: Prospective cohort study. PARTICIPANTS: A total of 287 medical inpatients with unhealthy alcohol use. MAIN MEASURES: At baseline and 12 months later, consumption and alcohol-related consequences were assessed. The outcome of interest was a favorable drinking outcome at 12 months (abstinence or drinking "moderate" amounts without consequences). The independent variables evaluated included demographics, physical/sexual abuse, drug use, depressive symptoms, alcohol dependence, commitment to change (Taking Action), spending time with heavy-drinking friends and receipt of alcohol treatment (after hospitalization). Adjusted regression models were used to evaluate factors associated with a favorable outcome. KEY RESULTS: Thirty-three percent had a favorable drinking outcome 1 year later. Not spending time with heavy-drinking friends [adjusted odds ratio (AOR) 2.14, 95% CI: 1.14-4.00] and receipt of alcohol treatment [AOR (95% CI): 2.16(1.20-3.87)] were associated with a favorable outcome. Compared to the first quartile (lowest level) of Taking Action, subjects in the second, third and highest quartiles had higher odds of a favorable outcome [AOR (95% CI): 3.65 (1.47, 9.02), 3.39 (1.38, 8.31) and 6.76 (2.74, 16.67)]. CONCLUSIONS: Although most medical inpatients with unhealthy alcohol use continue drinking at-risk amounts and/or have alcohol-related consequences, one third are abstinent or drink "moderate" amounts without consequences 1 year later. Not spending time with heavy-drinking friends, receipt of alcohol treatment and commitment to change are associated with this favorable outcome. This can inform efforts to address unhealthy alcohol use among patients who often do not seek specialty treatment.

Projecte d’implantació d’un cultiu d’arbres de fusta noble a la finca El Portet de Les Planes d’Hostoles (La Garrotxa)

El projecte té per finalitat la implantació d’un cultiu d’arbres de fusta d’alt valor econòmic en uns terrenys que actualment estan ocupats per prats de pastura abandonats. L’objectiu prioritari que es proposa és augmentar el rendiment de la finca objecte d’estudi. Per assolir-lo es projectarà la realització d’una plantació sostenible de noguers híbrids (Juglans regia×nigra) i cirerers (Prunus avium), en la que s’aplicaran les més avançades tècniques de cultiu i una eficient metodologia que permetrà obtenir fusta noble en cicles productius curts, sempre de forma respectuosa amb el medi ambient

La actualidad de las vacunas, a debate en el VII Forovax 2013

Boletín semanal para profesionales sanitarios de la Secretaría General de Calidad, Innovación y Salud Pública de la Consejería de Igualdad, Salud y Políticas Sociales

Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report.

During the last decade, we have been developing new therapeutic strategies for the treatment of renal cancer, based on knowledge derived from molecular biology. We report a case of long-term renal metastatic cancer progression despite therapy with sunitinib and interleukin, which are the most active drugs in renal cancer. Disease stabilization for 58 weeks was achieved upon sequential use of temsirolimus, following the occurrence of disease progression during angiogenic therapy. The patient demonstrated excellent tolerance without marked symptoms for 10 months. Hypothyroidism and mumps-related adverse events were present. The survival time from diagnosis to lung metastasis was 8 years. Thus, this case demonstrates promising therapeutic effects of the sequential use of tyrosine kinase inhibitors (TKIs) and mammalian target of rapamycin (mTOR) inhibitors during different stages of the disease.

Diabetes in Africa: the situation in the Seychelles

Comment on: Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 2008; 94: 1376-1382. doi: 10.1136/hrt.2008.147306. PMID: 18519551.